Roche's Copegus Meets Generic Competition
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA approves ANDAs filed by Three Rivers, Teva and Zydus, with Three Rivers offering a higher-dose tablet than currently available from the brand company.